State Street Corp Immunity Bio, Inc. Transaction History

State Street Corp

  • $2.8 Trillion
  • Q3 2025

A detailed history of State Street Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 11,315,813 shares of IBRX stock, worth $23.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,315,813
Previous 7,615,566 48.59%
Holding current value
$23.5 Million
Previous $20.1 Million 38.45%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$2.24 - $3.01 $8.29 Million - $11.1 Million
3,700,247 Added 48.59%
11,315,813 $27.8 Million
Q2 2025

Aug 14, 2025
BUY
$1.89 - $3.44 $59,846 - $108,927
31,665 Added 0.42%
7,615,566 $20.1 Million
Q1 2025

May 15, 2025
SELL
$2.32 - $3.9 $5.11 Million - $8.58 Million
-2,201,256 Reduced 22.5%
7,583,901 $22.8 Million
Q4 2024

Feb 14, 2025
BUY
$2.56 - $6.17 $2.89 Million - $6.98 Million
1,130,697 Added 13.06%
9,785,157 $25.1 Million
Q3 2024

Nov 14, 2024
BUY
$3.32 - $6.7 $2.62 Million - $5.3 Million
790,408 Added 10.05%
8,654,460 $32.1 Million
Q2 2024

Aug 14, 2024
SELL
$4.82 - $9.15 $30.5 Million - $57.8 Million
-6,320,225 Reduced 44.56%
7,864,052 $49.7 Million
Q1 2024

May 15, 2024
BUY
$3.23 - $6.17 $15.2 Million - $29.1 Million
4,713,368 Added 49.77%
14,184,277 $76.2 Million
Q4 2023

Feb 14, 2024
BUY
$1.25 - $5.21 $8.44 Million - $35.2 Million
6,751,317 Added 248.25%
9,470,909 $47.5 Million
Q3 2023

Nov 14, 2023
SELL
$1.29 - $3.1 $74,360 - $178,696
-57,644 Reduced 2.08%
2,719,592 $4.6 Million
Q2 2023

Aug 14, 2023
BUY
$1.53 - $6.41 $194,957 - $816,781
127,423 Added 4.81%
2,777,236 $7.72 Million
Q1 2023

May 15, 2023
SELL
$1.35 - $4.78 $5.52 Million - $19.5 Million
-4,086,238 Reduced 60.66%
2,649,813 $4.82 Million
Q4 2022

Feb 14, 2023
BUY
$4.35 - $6.77 $377,231 - $587,094
86,720 Added 1.3%
6,736,051 $34.2 Million
Q3 2022

Nov 15, 2022
BUY
$3.65 - $6.43 $17.4 Million - $30.7 Million
4,780,807 Added 255.86%
6,649,331 $33 Million
Q2 2022

Aug 15, 2022
SELL
$2.68 - $6.14 $13.1 Million - $30 Million
-4,891,782 Reduced 72.36%
1,868,524 $6.95 Million
Q1 2022

May 16, 2022
BUY
$5.05 - $7.53 $2.75 Million - $4.1 Million
544,929 Added 8.77%
6,760,306 $37.9 Million
Q4 2021

Feb 14, 2022
BUY
$5.67 - $10.18 $5.09 Million - $9.14 Million
897,597 Added 16.88%
6,215,377 $37.8 Million
Q3 2021

Nov 15, 2021
BUY
$9.17 - $14.24 $10.3 Million - $16 Million
1,124,160 Added 26.81%
5,317,780 $51.8 Million
Q2 2021

Aug 16, 2021
BUY
$13.41 - $22.4 $25 Million - $41.7 Million
1,861,048 Added 79.79%
4,193,620 $59.9 Million
Q1 2021

May 17, 2021
BUY
$12.83 - $42.25 $29.9 Million - $98.6 Million
2,332,572 New
2,332,572 $55.4 Million

Others Institutions Holding IBRX

# of Institutions
297
Shares Held
137M
Call Options Held
2.59M
Put Options Held
3.35M
View Full List

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $833M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email